Royce Fam

Royce Fam currently serves as a Project Manager at LionTCR Pte Ltd, where he plays a pivotal role in overseeing the company's innovative immunotherapy clinical trials. With over 14 years of extensive experience in clinical research, Royce brings a deep understanding of GCP, ICH-GCP standards, and regulatory compliance, ensuring that each trial adheres to the highest industry standards. His expertise spans managing complex clinical trial operations across Singapore and China, where he coordinates multidisciplinary teams, liaises with CROs, and maintains rigorous oversight of trial timelines, budgets, and quality assurance processes.

In his current role, Royce is instrumental in establishing and refining standard operating procedures (SOPs) that facilitate seamless trial execution while ensuring compliance with regulatory requirements set forth by authorities such as the HSA and China's NMPA. His strategic approach involves meticulous planning and risk management, which are critical in fast-paced biotech environments focused on developing cutting-edge immunotherapies for cancer. Royce’s responsibilities also include representing the company in regulatory submissions, audits, and stakeholder engagements, demonstrating his strong communication and negotiation skills.

A key project under his leadership involves the management of a multicenter clinical trial evaluating novel T-cell therapies, where he oversees trial site initiation, monitoring, and data integrity. His proficiency in clinical research, statistics, and life sciences enables him to troubleshoot operational challenges effectively, ensuring timely and compliant trial completion. Royce’s dedication to advancing cancer immunotherapy research underscores his commitment to innovation and excellence in clinical trial management.